Hypophosphatemic Rickets in Norway
This trial is active, not recruiting.
|Conditions||hypophosphatemia, familial, rickets, hyperphosphatemia|
|Treatments||alfacalcidol; phosphate., sevelamer|
|Sponsor||Haukeland University Hospital|
|Start date||December 2009|
|End date||December 2018|
|Trial size||80 participants|
|Trial identifier||NCT01057186, 21922|
The purpose of the study is to do a follow-up survey of all individuals with hereditary hypophosphatemia in Norway, focusing on manifestations in childhood and adolescence. The investigators also want to study phenotype-genotype associations, and look for new genes, in all forms of hereditary hypo and hyperphosphatemia.
time frame: Up to 18 years
Male or female participants of any age.
Inclusion Criteria: - All patients in the Norwegian population with hereditary hypophosphatemia, with or without rickets - Patients in the Norwegian population with hereditary hyperphosphatemia Exclusion Criteria:
|Official title||Hypophosphatemic Rickets in Norway|
Call for more information